Knoll gets FDA ok for hypertension drug . Knoll Pharmaceutical Co said Friday that the Food and Drug Administration has cleared TARKA , Knoll ' s hypertension drug , for marketing . Beginning in January TARKA should be available nationwide in four strengths , Knoll said . The drug is indicated for treating hypertension as second line therapy for patients who need more than a single agent therapy , Knoll said . 
